01334nas a2200229   4500000000100000008004100001260001200042653001600054653002000070653001200090653002400102653001200126100001400138700001300152700001200165700001400177245009100191856010500282300000800387520068400395022002501079       2024                            d  bMedknow10aDermatology10aDrug Resistance10aLeprosy10amorphological index10arelapse1 aChhabra N1 aKumar TS1 aSingh I1 aGanguly S00aMorphological Index as a Sensitive Marker of Drug Resistance in Leprosy: A Case Series  uhttps://journals.lww.com/ijd/fulltext/9900/morphological_index_as_a_sensitive_marker_of_drug.19.aspx  a1-43 a<p>Resistance to antileprosy drugs is one of the main contributors for the persistence of leprosy in the present era. In the absence of universal antimicrobial resistance (AMR) surveillance through the national program, the indications for resistance testing remain a important dilemma to clinicians. WHO recommendations mainly focus on clinical relapse, which could be picked up late with continued transmission and repeated leprosy reactions in the patient. We report here a series of eighteen leprosy cases who were tested for AMR in view of the positive morphological index after completion of multidrug therapy, chronic Erythema nodosum leprosum, and clinical relapse.</p>
  a0019-5154, 1998-3611